ergometrine



ergometrine


SMILES C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
InChIKey WVVSZNPYNCNODU-XTQGRXLLSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 3
Molecular weight (Da) 325.2

Database connections

Ligand site mutations 5-HT2A 5-HT2C

No bioactivity data available.

ergometrine


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV

Database connections

Ligand site mutations 5-HT2A 5-HT2C

Compound is not listed as a drug.